195 related articles for article (PubMed ID: 17598085)
1. Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.
Ren B; O'Brien BA; Swan MA; Koina ME; Nassif N; Wei MQ; Simpson AM
Diabetologia; 2007 Sep; 50(9):1910-1920. PubMed ID: 17598085
[TBL] [Abstract][Full Text] [Related]
2. Long-term reversal of diabetes in non-obese diabetic mice by liver-directed gene therapy.
Ren B; O'Brien BA; Byrne MR; Ch'ng E; Gatt PN; Swan MA; Nassif NT; Wei MQ; Gijsbers R; Debyser Z; Simpson AM
J Gene Med; 2013 Jan; 15(1):28-41. PubMed ID: 23293075
[TBL] [Abstract][Full Text] [Related]
3. Partial pancreatic transdifferentiation of primary human hepatocytes in the livers of a humanised mouse model.
Ren B; La QT; O'Brien BA; Nassif NT; Tan Y; Gerace D; Martiniello-Wilks R; Torpy F; Dane AP; Alexander IE; Simpson AM
J Gene Med; 2018 May; 20(5):e3017. PubMed ID: 29578255
[TBL] [Abstract][Full Text] [Related]
4. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.
Fodor A; Harel C; Fodor L; Armoni M; Salmon P; Trono D; Karnieli E
Diabetologia; 2007 Jan; 50(1):121-30. PubMed ID: 17131142
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic transdifferentiation in porcine liver following lentiviral delivery of human furin-cleavable insulin.
Gerace D; Ren B; Hawthorne WJ; Byrne MR; Phillips PM; O'Brien BA; Nassif N; Alexander IE; Simpson AM
Transplant Proc; 2013 Jun; 45(5):1869-74. PubMed ID: 23769060
[TBL] [Abstract][Full Text] [Related]
6. Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes.
Erendor F; Eksi YE; Sahin EO; Balci MK; Griffith TS; Sanlioglu S
Mol Ther; 2021 Jan; 29(1):149-161. PubMed ID: 33130311
[TBL] [Abstract][Full Text] [Related]
7. Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction.
Elsner M; Terbish T; Jörns A; Naujok O; Wedekind D; Hedrich HJ; Lenzen S
Mol Ther; 2012 May; 20(5):918-26. PubMed ID: 22354377
[TBL] [Abstract][Full Text] [Related]
8. Diabetes therapy by lentiviral hepatic insulin gene expression without transformation of liver.
Elsner M; Jörns A; Lenzen S
Diabetologia; 2008 Apr; 51(4):694-5; author reply 696. PubMed ID: 18239907
[No Abstract] [Full Text] [Related]
9. Regulated hepatic insulin gene therapy of STZ-diabetic rats.
Thulé PM; Liu JM
Gene Ther; 2000 Oct; 7(20):1744-52. PubMed ID: 11083496
[TBL] [Abstract][Full Text] [Related]
10. Glucose-regulated insulin production in hepatocytes.
Alam T; Sollinger HW
Transplantation; 2002 Dec; 74(12):1781-7. PubMed ID: 12499898
[TBL] [Abstract][Full Text] [Related]
11. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue.
Lee HC; Kim SJ; Kim KS; Shin HC; Yoon JW
Nature; 2000 Nov; 408(6811):483-8. PubMed ID: 11100731
[TBL] [Abstract][Full Text] [Related]
12. Long-term glycemic control with hepatic insulin gene therapy in streptozotocin-diabetic mice.
Thulé PM; Campbell AG; Jia D; Lin Y; You S; Paveglio S; Olson DE; Kozlowski M
J Gene Med; 2015; 17(8-9):141-52. PubMed ID: 26190010
[TBL] [Abstract][Full Text] [Related]
13. A step toward liver gene therapy: efficient correction of the genetic defect of hepatocytes isolated from a patient with Crigler-Najjar syndrome type 1 with lentiviral vectors.
Birraux J; Menzel O; Wildhaber B; Jond C; Nguyen TH; Chardot C
Transplantation; 2009 Apr; 87(7):1006-12. PubMed ID: 19352119
[TBL] [Abstract][Full Text] [Related]
14. Nonvirally modified autologous primary hepatocytes correct diabetes and prevent target organ injury in a large preclinical model.
Chen NK; Wong JS; Kee IH; Lai SH; Thng CH; Ng WH; Ng RT; Tan SY; Lee SY; Tan ME; Sivalingam J; Chow PK; Kon OL
PLoS One; 2008 Mar; 3(3):e1734. PubMed ID: 18320053
[TBL] [Abstract][Full Text] [Related]
15. Defective adenoassociated viral-mediated transfection of insulin gene by direct injection into liver parenchyma decreases blood glucose of diabetic mice.
Sugiyama A; Hattori S; Tanaka S; Isoda F; Kleopoulos S; Rosenfeld M; Kaplitt M; Sekihara H; Mobbs C
Horm Metab Res; 1997 Dec; 29(12):599-603. PubMed ID: 9497894
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of adeno-associated viral vector-mediated insulin gene transfer via portal vein to the livers of streptozotocin-induced diabetic Sprague-Dawley rats.
Park YM; Woo S; Lee GT; Ko JY; Lee Y; Zhao ZS; Kim HJ; Ahn CW; Cha BS; Kim KS; Park CW; Lee HC
J Gene Med; 2005 May; 7(5):621-9. PubMed ID: 15651056
[TBL] [Abstract][Full Text] [Related]
17. Hepatic insulin gene therapy diminishes liver glycogen despite insulin responsive transcriptional effects in diabetic CD-1 mice.
Zhang JA; Jia D; Olson DE; Campbell AG; Thulé PM
J Gene Med; 2009 Jul; 11(7):588-97. PubMed ID: 19434628
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy of streptozotocin-induced diabetes by intramuscular delivery of modified preproinsulin genes.
Croze F; Prud'homme GJ
J Gene Med; 2003 May; 5(5):425-37. PubMed ID: 12731091
[TBL] [Abstract][Full Text] [Related]
19. Hepatic insulin expression improves glycemic control in type 1 diabetic rats.
Dong H; Morral N; McEvoy R; Meseck M; Thung SN; Woo SL
Diabetes Res Clin Pract; 2001 Jun; 52(3):153-63. PubMed ID: 11323084
[TBL] [Abstract][Full Text] [Related]
20. Insulin expression in livers of diabetic mice mediated by hydrodynamics-based administration.
He CX; Shi D; Wu WJ; Ding YF; Feng DM; Lu B; Chen HM; Yao JH; Shen Q; Lu DR; Xue JL
World J Gastroenterol; 2004 Feb; 10(4):567-72. PubMed ID: 14966918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
